| 7.0 |
55.8 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 6.3 |
37.7 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.0 |
2.9 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 1.0 |
8.8 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.8 |
26.2 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.7 |
12.8 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.6 |
2.9 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.6 |
2.3 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.5 |
1.6 |
GO:0090526 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.5 |
4.3 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.5 |
2.3 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.4 |
1.2 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.4 |
5.0 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.4 |
6.8 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.4 |
8.6 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.4 |
1.1 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.4 |
1.1 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.3 |
1.0 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.3 |
1.1 |
GO:0032512 |
regulation of protein phosphatase type 2B activity(GO:0032512) positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.3 |
0.8 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.3 |
4.4 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.2 |
1.4 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
3.7 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.2 |
3.2 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 |
1.8 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.2 |
9.3 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.2 |
2.5 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.2 |
1.0 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.2 |
1.1 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 |
0.4 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.1 |
1.2 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.1 |
0.9 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.9 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
1.6 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.3 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.3 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 |
2.1 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.1 |
3.4 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
1.1 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.1 |
1.4 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.1 |
0.4 |
GO:0032782 |
urea transport(GO:0015840) bile acid secretion(GO:0032782) urea transmembrane transport(GO:0071918) |
| 0.1 |
0.6 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.3 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.0 |
1.6 |
GO:0061028 |
establishment of endothelial barrier(GO:0061028) |
| 0.0 |
1.7 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.0 |
1.7 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.0 |
1.2 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
3.4 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 |
6.0 |
GO:1901652 |
response to peptide(GO:1901652) |
| 0.0 |
0.4 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.0 |
1.5 |
GO:0045786 |
negative regulation of cell cycle(GO:0045786) |
| 0.0 |
0.9 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.5 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
0.6 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.2 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.0 |
0.3 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
1.2 |
GO:0000077 |
DNA damage checkpoint(GO:0000077) |
| 0.0 |
0.9 |
GO:0008344 |
adult locomotory behavior(GO:0008344) |
| 0.0 |
0.7 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
